When’s the Best Time to Get Your Flu and COVID Shots?
By Associated Press Source Medpagetoday If you missed the early fall pushopens in a new tab or window for flu and COVID-19 vaccines, it's not too...
Vaccination
Rebound in epidemic control: how misaligned vaccination timing amplifies infection peaks
By Piergiorgio Castioni et al. Source Nature 疫苗加遽感染，新冠病毒更强 Researchers have found that] the timing of vaccination and subsequent immunity waning can...
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
By August F. Jernbom et al. Source Nature Researchers found on the new-onset autoantibody repertoire in 525 healthcare workers and hospitalized...
Tissue resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge
By Abby Odle et al. Source JCI Insight This study found that mice previously infected with recent SARS-CoV-2 variants like Omicron were protected...
COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says
By Katherine Kahn Source Medpagetoday The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against...
Stroke risks in patients with COVID‐19: multiple mechanisms of SARS‐CoV‐2, impact of sex and age, vaccination, and long‐term infection
By Moawiah M. Naffaa et al. Source Springer Abstract The COVID-19 pandemic has presented unprecedented challenges to the healthcare system,...
Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China
By Jing Wu et al. Source ASM ABSTRACT It remains unclear how previous infections and vaccinations influenced and shaped heterogeneous immune...
Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras
By Melanie D Swift et al. Source Oxford academic Structured Abstract Background Uncertainty exists regarding the effectiveness of COVID-19 vaccine...
Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago
By Fabiola Moreno EchevarriaI et al. Source PLOS ONE SARS-CoV-2 vaccines are safe and effective against infection and severe COVID-19 disease...
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
By Margherita Bellucci et al. Source Frontiers Introduction: A potential overlap in symptoms between post-acute COVID-19 syndrome and post-COVID-19...